We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Bacterial Populations Rapidly Evolve a Time-linked Tolerance to Antibiotics

By LabMedica International staff writers
Posted on 14 Jul 2014
Print article
A team of molecular microbiologists has found that some types of bacteria develop tolerance towards antibiotic treatment by "learning" how to time the length of exposure to the drug and evolving an extended period of dormancy that protects the organisms from the effects of the antibiotic.

Investigators at the Hebrew University of Jerusalem (Israel) followed the evolution of bacterial populations under intermittent exposure to the high concentrations of antibiotics used in the clinic and characterized the evolved strains in terms of both resistance (growth of microorganisms in the constant presence of an antibiotic, provided that the concentration of the antibiotic is not too high) and tolerance (survival of microorganisms during antibiotic treatment, even at high antibiotic concentrations, as long as the duration of the treatment is limited).

Initially bacterial populations were treated with antibiotics for three hours each day. Exposure times were later increased to five and eight hours per day.

By monitoring the phenotypic changes at the population and single-cell levels, the investigators found that after only 10 days the first adaptive change to antibiotic stress became apparent. This was the development of tolerance towards the antibiotic through a major adjustment in the single-cell lag-time distribution, without a change in resistance. They also found that the lag time of bacteria before regrowth was optimized to match the duration of the antibiotic-exposure interval. All bacterial strains adapted by specific genetic mutations, which became fixed in the evolved populations.

The investigators also reported that whole genome sequencing of the evolved strains and restoration of the wild-type alleles allowed the identification of target genes involved in this antibiotic-driven phenotype, which they called "tolerance by lag" (tbl).

The results of this study, which was published in the June 25, 2014, online edition of the journal Nature, demonstrated that bacteria can evolve within days. The investigators expect that better understanding of lag-time evolution as a key determinant of the survival of bacterial populations under high antibiotic concentrations will lead to new approaches to preventing the evolution of antibiotic resistance.

Related Links:

Hebrew University of Jerusalem


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: AI analysis of DNA fragmentomes and protein biomarkers noninvasively detects ovarian cancer (Photo courtesy of Adobe Stock)

Blood-Based Machine Learning Assay Noninvasively Detects Ovarian Cancer

Ovarian cancer is one of the most common causes of cancer deaths among women and has a five-year survival rate of around 50%. The disease is particularly lethal because it often doesn't cause symptoms... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more

Pathology

view channel
Image: The device can serve as a sample pretreatment tool for cytological diagnosis of malignant effusions (Photo courtesy of Microsystems & Nanoengineering: Zhu, Z., Ren, H., Wu, D. et al.)

Microfluidic Device for Cancer Detection Precisely Separates Tumor Entities

Tumor cell clusters are increasingly recognized as crucial in cancer pathophysiology, with growing evidence of their increased resistance to treatment and higher metastatic potential compared to single tumor cells.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.